TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Est. Return
18.15%
1 Year Est. Return
+18.15%
AUM
$2.63B
AUM Growth
-$21.2M
(-0.8%)
Holding
190
Top Buys
| 1 | +$45.7M | |
| 2 | +$22.8M | |
| 3 | +$19.9M | |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$18.2M |
| 5 |
Exelixis
EXEL
|
+$14.1M |
Top Sells
| 1 | +$47.2M | |
| 2 | +$26.4M | |
| 3 | +$24.7M | |
| 4 |
Lantheus
LNTH
|
+$21.7M |
| 5 |
Humana
HUM
|
+$19.9M |
Sector Composition
| 1 | Healthcare | 96.54% |
| 2 | Real Estate | 2.01% |
| 3 | Industrials | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLCM
176
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.98K | ﹤0.01% |
6,000
|
|
||
177
IDEAYA Biosciences
IDYA
$2.95B
| – | – |
-133,185
|
|
||
178
MoonLake Immunotherapeutics
MLTX
$887M
| – | – |
-300,000
|
|
||
179
Pliant Therapeutics
PLRX
$91.6M
| – | – |
-35,233
|
|
||
180
Protagonist Therapeutics
PTGX
$5.29B
| – | – |
-122,271
|
|
||
181
Stevanato
STVN
$6.03B
| – | – |
-71,190
|
|
||
182
Xencor
XNCR
$1.14B
| – | – |
-200,328
|
|
||
|
MORF
183
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-44,625
|
|
||
|
ALR
184
DELISTED
AlerisLife Inc
ALR
| – | – |
-24,237
|
|
||
185
Acadia Pharmaceuticals
ACAD
$4.3B
| – | – |
-72,225
|
|
||
186
Arvinas
ARVN
$749M
| – | – |
-42,998
|
|
||
187
HealthEquity
HQY
$8.52B
| – | – |
-110,214
|
|
||
|
ONEM
188
DELISTED
1Life Healthcare
ONEM
| – | – |
-31,266
|
|
||
|
HZNP
189
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-415,053
|
|